EGFR GENE MUTATION

Clinical trials for EGFR GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new EGFR GENE MUTATION trials appear

Sign up with your email to follow new studies for EGFR GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 6 Completed 3

CRISPR therapy targets Hard-to-Treat lung cancer liver tumors

Disease control Not yet recruiting

This early-stage study tests a new gene-editing drug called EDB-102 in 15 adults with advanced non-small cell lung cancer that has spread to the liver and is no longer responding to standard targeted therapy. The drug uses CRISPR technology to find and disable a specific cancer-c…

Matched conditions: EGFR GENE MUTATION

Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated May 17, 2026 02:20 UTC

EGFR GENE MUTATION

Get alerted when new EGFR GENE MUTATION trials appear

CRISPR therapy targets Hard-to-Treat lung cancer liver tumors